This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Truist Financial Reaffirms Their Buy Rating on Chemours Company (CC)

Tipranks - Tipranks - Thu Jun 18, 11:26PM CDT

In a report released yesterday, Pete Osterland from Truist Financial maintained a Buy rating on Chemours Company. The company’s shares closed yesterday at $22.02.

Claim 55% Off TipRanks

According to TipRanks, Osterland is a 5-star analyst with an average return of 33.9% and a 77.61% success rate. Osterland covers the Basic Materials sector, focusing on stocks such as TRONOX, Chemours Company, and Albemarle.

Chemours Company has an analyst consensus of Moderate Buy, with a price target consensus of $25.75.

See Insiders’ Hot Stocks on TipRanks >>

Based on Chemours Company’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $1.38 billion and a GAAP net loss of $29 million. In comparison, last year the company earned a revenue of $1.37 billion and had a GAAP net loss of $4 million

Read More on CC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).